跳至主要内容
临床试验/EUCTR2009-016417-15-FR
EUCTR2009-016417-15-FR进行中(未招募)不适用

Fondaparinux population pharmacokinetic to morbid obese patients in post-operatory bariatric surgery

CHU de SAINT-ETIENNE0 个研究点开始时间: 2009年11月26日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age = 18 years old
  • - requiring a bariactric surgery
  • - requiring an antithrombotics prophylaxis
  • - having a morbid obesity based on a BMI >40 kg/m2
  • - having signed the inform consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - contra-indication to fondaparinux
  • - history of heparin induced thrombopenia (HIT)
  • - platelets < 100 G/l
  • - requiring an effective antithrombotic treatment
  • - aptients with justice protection

研究者

发起方
CHU de SAINT-ETIENNE

相似试验

Fondaparinux population pharmacokinetic to morbid... | 临床试验